5Rizzoni D, Pasini E, Flati V, et al. Angiotensin receptor blockers im- prove insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneous-ly hypertensive rats. J Hypertens, 2008 ; 26 ( 8 ) : 1595 - 1601.
6Aceto JF, Baker KM. Angiotensin II receptor-midiated stimulation of pro- tein syn-thesis in chick heart cell. Am J Physiol, 1990; 258(3 Pt 2) : H806 - H813.
7Junichi Suzuki, Hiroaki Matsubara, Masaya Umkami, et al. Rat angio- tensin II (Ty-pe 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circulation Research, 1993 ; 73 ( 3 ) : 439 - 447.
8Nakao N, Yoshimura A, Morita H, et a/.Combination treat- ment of angiotensin- II receptor blocker and angiotensin- converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE) :a randomised controlled trial[J].Lancet, 2003(9 352):117.
9Schmieder RE, Klingbeil AU, Fleischmann EH, et al.Addi- tional antiproteinuric effect of ultrahigh dose candesartan: a double-blind, randomized, prospective study[J].J Am Soc Nephrol, 2005,16(10) : 3 038.
10Parving HH, Lehnert H, BriSchner-Mortensen J, et al. The effect of irbesartan on the development of diabetic ne- phropathy in patients with type 2 diabetes[J].N Engl J Med, 2001,345 (12) :870.
